BlueCrest Capital Management’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-17,966
Closed -$124K 670
2019
Q2
$124K Buy
17,966
+2,874
+19% +$20.4K 0.01% 369
2019
Q1
$108K Sell
15,092
-7,012
-32% -$63.6K ﹤0.01% 1069
2018
Q4
$218K Buy
22,104
+852
+4% +$8.84K 0.01% 619
2018
Q3
$254K Sell
21,252
-177,056
-89% -$1.6M 0.01% 1132
2018
Q2
$1.83M Buy
198,308
+166,513
+524% +$1.5M 0.05% 331
2018
Q1
$252K Buy
+31,795
New +$268K 0.01% 1165
2016
Q3
Sell
-21,502
Closed -$449K 979
2016
Q2
$449K Buy
+21,502
New +$384K 0.02% 561

Other funds holding SWBI

BlueCrest Capital Management's SWBI Position: Q3 2019 in Review

BlueCrest Capital Management sold out of Smith & Wesson (SWBI) in Q3 2019, closing a stake of 17,966 shares — an estimated $124K sold.

BlueCrest Capital Management first reported a position in SWBI in Q2 2016 and held it in 7 quarters. The position peaked at $1.83M in Q2 2018. 151 funds tracked by Wall St. Rank hold SWBI as of Q3 2019.

  • BlueCrest Capital Management reported no remaining Smith & Wesson position as of Q3 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 17,966 Smith & Wesson shares in Q3 2019, an estimated $124K.
  • BlueCrest Capital Management first reported a position in Smith & Wesson in Q2 2016 and held it in 7 quarters.
  • BlueCrest Capital Management's Smith & Wesson position peaked at $1.83M in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Smith & Wesson as of Q3 2019.

Based on BlueCrest Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.